Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - April 2025
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - April 2025
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • RR-April-2025-half-cover
      April 2025 – Contents
    • licensed April issue cover
      Africa and the MENA region: Opportunities for growth
    • March half cover
      March 2025 – Contents
  • Veterinary
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
    • SUSIMPERATIVE_compressed
      The sustainability imperative for the healthcare sector
    • AdobeStock_537705324
      New data protection for maximum residue limits
    • AdobeStock_294025271
      EMA platform to monitor use of antimicrobials
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • MDR-innovation-compressed
      The EU Medical Device Regulation: Balancing innovation with regulation
    • final licensed cover image_compressed
      Medical device regulation: Challenges, innovation and the future
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Medical devices/IVDs sessions
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • MHRA safety licensed image
      MHRA provides guidance to streamline safety communication
    • Chimwemwe Chamdimba
      Key milestone reached in African medicines regulation
    • 3. Rui Santos Ivo_image 3
      Rui Santos Ivo elected as new Chair of the EMA Management Board
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • TOPRA VetReg Podcast 800x533px (6.4 ratio)
      RegRapPod − InConversation with Ivo Claassen
    • licensed April issue cover
      Africa and the MENA region: Opportunities for growth
    • licensed front cover
      Data and AI: Readiness, research and real-world impact
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Symposium 2021
        • Annual lecture
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items

Pharmaceutical latest

  • RR-April-2025-half-cover

    April 2025 – Contents

    2025-04-03T14:48:00+01:00

  • licensed April issue cover

    Africa and the MENA region: Opportunities for growth

    2025-04-03T14:08:00+01:00

  • March half cover

    March 2025 – Contents

    2025-03-04T12:51:00+00:00

  • licensed front cover

    Data and AI: Readiness, research and real-world impact

    2025-03-04T12:22:00+00:00

  • FOETALPIP

    Regulatory strategy implications for foetal medicine

    2025-02-07T12:35:00+00:00

  • Immune1 final licensed image

    Immunological considerations in the development of novel vaccines

    2025-02-07T12:35:00+00:00



  • Immune1 final licensed image

    Immunological considerations in the development of novel vaccines

    2025-02-07T12:35:00+00:00

  • RR-Feb-2025-half cover

    February 2025 – Contents

    2025-02-06T15:51:00+00:00

  • EPI Podcast 800x533px (6.4 ratio)

    RegRapPod − InConversation with the UK ePI Task Force

    2025-02-04T17:00:00+00:00

  • ROLEOFAI_final_compressed

    The role of artificial intelligence in regulatory affairs

    2025-01-10T08:54:00+00:00

  • GENDEVS

    Considerations for generics developers moving into the field of biosimilars

    2025-01-10T08:49:00+00:00

  • RR-Jan-2025- half cover

    January 2025 – Contents

    2025-01-08T17:19:00+00:00

  • RR-Nov-2024-Half-Cover

    November 2024 – Contents

    2024-12-06T15:14:00+00:00

  • final article image

    Early development of vaccines and prophylactics in infectious diseases: A post-pandemic regulatory overview

    2024-12-06T11:55:00+00:00

  • CTR article image final

    Transitioning to the Clinical Trials Regulation: The Roche experience

    2024-12-06T11:55:00+00:00

  • final image

    Shedding light on essential drug delivery outputs

    2024-12-06T11:54:00+00:00

  • AdobeStock_823948113

    Notable US Food and Drug Administration pilot programmes

    2024-12-06T11:53:00+00:00

  • final article image

    Health Canada: Points to consider when preparing quality and new substance notification documentation for investigational medicinal products

    2024-12-06T11:53:00+00:00

More pharmaceutical content

  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud